Nanjing Pharmaceutical Co. Ltd.

Pharmaceuticals
China
2016 Revenue (US$ Millions)$3,848
Revenue Growth (%)7.69%
Net Income (US$ Millions)$26
Earnings Per Share (US$)$0.03
EPS Growth Rate (%)14.86%
Profit Margin0.67%
Total Equity (US$ Millions)$378
Return on Equity (%)7.83%
Long Term Debt (US$ Millions)$0
Debt To Equity Ratio (%)0.00%
Total Assets (US$ Millions)$2,011
Current Assets (US$ Millions)$1,790
Current Liabilities (US$ Millions)$1,543
Cost of Goods Sold (US$ Millions)$3,622
Inventory Turnover10.80